Mechanisms of tolerance
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Go to http://www.immunologicalreviews.com to watch interview with Guest Editor Jeffrey A. Bluestone Productive immune responses to foreign antigens are necessary to protect individuals against pathogens and allow survival in the external environment. The immune system has evolved to achieve efficient immunity against foreign antigens without mounting detrimental responses to self-antigens, thus preserving the integrity of the individual's own tissues. This original paradigm of immune tolerance has developed to include not only the spontaneous absence of self-targeted responses in steady state or after an inflammatory response but also the pharmacologically induced state of non-responsiveness to foreign antigens deliberately introduced into individuals, such as organ grafts. Thus, tolerance can be defined as a lack of reactivity to self-antigens or foreign tissue antigens in an organ graft achieved without the need for long-term immunosuppression while retaining immune competence and reactivity to all other foreign antigens. From an evolutionary point-of-view, the critical importance of immune tolerance is illustrated by the multiple non-redundant mechanisms that are in place to establish this immunological state. Nevertheless, the challenges in attaining and maintaining this state are underlined by the prevalence of autoimmune diseases, the as-of-yet absence of routine tolerogenic therapies in organ transplantation, and the necessity to strike a balance between protecting the individual from autoimmunity while preserving responses against cancerous cells and foreign antigens. Central tolerance mechanisms eliminate many potentially autoreactive T cells in the thymus through negative selection and the preferred selection of thymocytes with high affinity to self toward the regulatory T-cell lineage. Yet, it is clear that potentially self-reactive thymocytes can pass this checkpoint and become a part of the peripheral T-cell repertoire. Peripheral tolerance mechanisms limit the activation of mature self-reactive T cells once they have exited the thymus. Autoreactive T cells may be tolerized by clonal deletion, anergy, or immunological ignorance. Their responses can be controlled by regulatory T cells (Tregs), B cells, or other regulatory leukocytes. It is notable that the concept of immunological tolerance was introduced more than 50 years ago by Medawar et al., well ahead of the characterization of basic features of immune responses as we know them now, such as the major histocompatibility complex (MHC)-restricted recognition of antigenic peptides by the T-cell receptor (TCR), the stages of thymic selection, or the existence of T-cell subsets and lineages, such as T-helper 1 (Th1), Th2, Th17 and Tregs. As narrated by Wood et al. in this issue (1), Medawar et al. observed that injection of allogeneic tissue into neonates led to immune tolerance to subsequent allografts (2). This led to the seminal concept that exposing the developing immune system to new antigens, including alloantigens, could induce specific immunological tolerance. The impact of this work has been tremendous and provided the basis to determine the mechanisms of tolerance and develop tolerogenic approaches in the clinic. Interestingly, plasticity of the immature immune system was noted as one of the keys to the success of the neonatal tolerance induction strategy in these early studies. The recent appreciation that there is also a certain degree of plasticity in mature T-cell subsets and dendritic cells (DCs) in the periphery suggests that the multi-level plasticity of the immune system is critical for the establishment of tolerance. Many other parameters have been proven to determine whether immune tolerance can be achieved (Fig. 1), including the route or location of antigen presentation (for example, oral administration of antigen or immunologically privileged sites favor tolerance), the source and form of antigen (dose, with or without adjuvant/inflammation, tissue antigen, etc.), the antigen-presenting cells (APCs) (cell types involved, e.g. B cells, monocytes/macrophages, DCs, non-professional APCs, etc., and their state of maturity and activation), cells responding to the stimulation (naive versus memory, effector versus regulatory T cells, size and avidity of the repertoire, etc.), cytokine milieu, the role of T-cell intrinsic signals versus extrinsic regulation, the genetic background, the environmental milieu, and the plasticity of tolerance (plasticity of T-cell subsets, role of innate immunity which can break tolerance, acknowledgment that tolerance itself is a dynamic state). Reviews in this volume of Immunological Reviews discuss many of these parameters and their influence on the induction or maintenance of immune tolerance. The individual reviews provide in-depth discussion of the data and contributions made in each area of tolerance. In this introduction, I summarize key elements in each review to achieve a coherent overall pi
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221 · cited 3×
“In this issue of Immunological Reviews, Ohashi et al. (57) review the requirements for breaking CD8+ tolerance that can lead to autoimmunity.”
BackgroundCTLA-4 Control over Foxp3 + Regulatory T Cell Function
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956 · cited 5×
“In fact, the combination of regulatory cells and suppressive factors, including anti-inflammatory molecules such as indoleamine 2,3-dioxygenase (IDO) and transforming growth factor-b (TGF-b), produced by the tumors themselves provide an ‘immune privileged’ site that mitigates immunity and enhances Treg activity.”
BackgroundInfluentialDAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794 · cited 2×
“production in the mitochondrial pathway of apoptosis (46)”
BackgroundAssociation of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175 · cited 1×
“The genetic association of polymorphisms in the CTLA-4 gene emphasizes the importance of CTLA-4 in tolerance with susceptibility to multiple autoimmune diseases in mice and humans (29).”
BackgroundRobust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
Finland, G. O. T. 1. D. I., Todd, J. A., the Wellcome Trust Case Control Consortium, Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2068 · Cited by 1,456
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Self-citationImmunogenic and tolerogenic cell death
Green, D. R., Ferguson, T., Zitvogel, L., & Kroemer, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2545 · Cited by 1,176 · cited 1×
“It is now clear that many factors, including the cell type undergoing death, the form of cell death (apoptosis versus necrosis), the degradation products produced by dying cells (for example, HMGB1, cholesterol crystals, heat shock proteins, or uric acid released by necrotic cells), the cytokine environment, and the m…”
BackgroundStability of the Regulatory T Cell Lineage in Vivo
Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., & Rudensky, A. Y. (2010) · Science · doi:10.1126/science.1191996 · Cited by 730 · cited 21×
“Both iTregs and AHR ligands condition DCs to produce IL-27 and retinoic acid and in turn induce IL-10-secreting Tr1 cells and amplify Treg induction.”
BackgroundInfluentialCentral Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
Tang, Q., Adams, J. Y., Penaranda, C., Melli, K., Piaggio, E., Sgouroudis, E., Piccirillo, C. A., Salomon, B. L., & Bluestone, J. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.016 · Cited by 729 · cited 21×
“Both iTregs and AHR ligands condition DCs to produce IL-27 and retinoic acid and in turn induce IL-10-secreting Tr1 cells and amplify Treg induction.”
BackgroundInfluentialSelf-citationKazama, H., Ricci, J.-E., Herndon, J. M., Hoppe, G., Green, D. R., & Ferguson, T. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.05.013 · Cited by 627 · cited 7×
“Thus, administration of gp peptides together with maturation of APCs with PAMPs (agonistic anti-CD40 monoclonal antibody or lipopolysaccharide) or DAMPs (HSP70) can lead to the activation of P14 cells and autoimmune diabetes in P14 ⁄RIP-gp mice.”
BackgroundInfluential
Cited by
Kim, C. J., Romero, R., Chaemsaithong, P., & Kim, J.-S. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.041 · Cited by 519
Is autoimmunity the Achilles' heel of cancer immunotherapy?
June, C. H., Warshauer, J. T., & Bluestone, J. A. (2017) · Nature Medicine · doi:10.1038/nm.4321 · Cited by 445
Self-citationAge-associated remodeling of T cell immunity and metabolism
Han, S., Georgiev, P., Ringel, A. E., Sharpe, A. H., & Haigis, M. C. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.005 · Cited by 193
T cells in the control of organ-specific autoimmunity
Bluestone, J. A., Bour-Jordan, H., Cheng, M., & Anderson, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78089 · Cited by 155
“Peripheral tolerance is achieved through T cell–intrinsic mechanisms that lead to clonal deletion, anergy, or immunological ignorance as well as extrinsic control by specialized populations of suppressor cells that regulate potentially harmful responses of autoreactive T and B cells (12, 13).”
BackgroundSelf-citationImmune mechanisms in type 1 diabetes
Wållberg, M., & Cooke, A. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.08.005 · Cited by 155
Metadata
- Authors
- Bluestone, J. A.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2011-04-13
- Volume
- 241
- Issue
- 1
- Pages
- 5-19
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W1492784163
- Cited by
- 119
- References
- 13
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanisms of tolerance. https://app.cochat.ai/papers/10.1111/j.1600-065x.2011.01019.x
- The paper
- Bluestone, J. A. (2011). Mechanisms of tolerance. Immunological Reviews. https://doi.org/10.1111/j.1600-065x.2011.01019.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.